Lovesac (LOVE)
(Delayed Data from NSDQ)
$21.84 USD
-0.01 (-0.05%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $21.90 +0.06 (0.27%) 7:58 PM ET
5-Strong Sell of 5 5
A Value A Growth D Momentum A VGM
Earnings News For LOVE
-
Lovesac (LOVE) Q4 Earnings & Net Sales Miss Estimates, Up Y/Y
-
Lovesac: Fiscal Q4 Earnings Snapshot
-
The Lovesac Company Reports Fourth Quarter and Fiscal 2024 Financial Results
-
Here's What to Expect From Lovesac's (LOVE) Q4 Earnings
-
The Lovesac Company to Announce Fourth Quarter and Fiscal 2024 Earnings Results
-
Lovesac (LOVE) Q3 Earnings & Revenues Beat Estimates, Up Y/Y
-
Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues
-
Lovesac: Fiscal Q3 Earnings Snapshot
-
The Lovesac Company Reports Third Quarter Fiscal 2024 Financial Results
-
Here's What to Expect From Lovesac's (LOVE) Q3 Earnings
-
Lovesac: Fiscal Q2 Earnings Snapshot
-
The Lovesac Company Reports Second Quarter Fiscal 2024 Financial Results
-
The Lovesac Company Reports Preliminary Second Quarter Fiscal Year 2024 Results
-
Lovesac (LOVE) Reports Q1 Loss, Tops Revenue Estimates
-
Lovesac: Fiscal Q1 Earnings Snapshot
-
The Lovesac Company Reports First Quarter Fiscal 2024 Financial Results
-
Lovesac: Fiscal Q4 Earnings Snapshot
-
Lovesac (LOVE) Misses Q4 Earnings Estimates
-
The Lovesac Company Reports Record Fourth Quarter and Fiscal 2023 Financial Results
-
The Lovesac Company to Announce Fourth Quarter and Fiscal 2023 Earnings Results
-
Lovesac (LOVE) Reports Q3 Loss, Lags Revenue Estimates
-
Lovesac: Fiscal Q3 Earnings Snapshot
-
The Lovesac Company Reports Third Quarter Fiscal 2023 Financial Results
-
Cannara Biotech Inc. Reports Record Q4 and 2022 Fiscal Year Financial Results
-
Lovesac (LOVE) Q2 Earnings and Revenues Beat Estimates